tirzepatide obstructive sleep apnea fda approval 2024 Zepbound just became the first drug ever FDA-approved for (Dec 2024). In the SURMOUNT-OSA trial — NEJM, n=469 — breathing events dropped ~60%, patients lost 18% of their body weight FDA Approves Tirzepatide (Zepbound) as

I think people should have a conversation with their practitioners or their doctor or provider and do their own individualized risk benefit analysis." The study analyzed medical records from October 2017 to December 2023 to create what Al-Aly called an atlas of association, mapping out the drugs effects throughout the body

Large meals can exacerbate feelings of fullness or nausea because the medication slows stomach emptying

GLP-1 medications can cause side effects ranging from mild nausea to severe complications like pancreatitis or kidney problems

Alcohol can independently cause both, especially in larger amounts

Patients should factor in required lab costs ($75, $200 per panel depending on the test set and lab), telehealth subscription fees, and shipping when calculating total monthly expense

By neutralizing these free radicals, glutathione IV reduces the inflammatory signals that lead to overproduction of melanin